Cinnamon Improves Glucose and Lipids of People With Typ2 Diabetes

Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes

Department of Human Nutrition, NWFP Agricultural University, Peshawar, Pakistan

Post Graduate Medical Institute, Hayatabad Medical Complex, Peshawar, Pakistan

Nutrients Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, Beltsville, Maryland

Address correspondence and reprint requests to Dr. Richard A. Anderson, Nutrient Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, Bldg. 307, Rm. 224, Beltsville, MD 20705. E-mail:

OBJECTIVEThe objective of this study was to determine whether cinnamon improves blood glucose, triglyceride, total cholesterol, HDL cholesterol, and LDL cholesterol levels in people with type 2 diabetes.

RESEARCH DESIGN AND METHODSA total of 60 people with type 2 diabetes, 30 men and 30 women aged 52.2 6.32 years, were divided randomly into six groups. Groups 1, 2, and 3 consumed 1, 3, or 6 g of cinnamon daily, respectively, and groups 4, 5, and 6 were given placebo capsules corresponding to the number of capsules consumed for the three levels of cinnamon. The cinnamon was consumed for 40 days followed by a 20-day washout period.

RESULTSAfter 40 days, all three levels of cinnamon reduced the mean fasting serum glucose (1829%), triglyceride (2330%), LDL cholesterol (727%), and total cholesterol (1226%) levels; no significant changes were noted in the placebo groups. Changes in HDL cholesterol were not significant.

CONCLUSIONSThe results of this study demonstrate that intake of 1, 3, or 6 g of cinnamon per day reduces serum glucose, triglyceride, LDL cholesterol, and total cholesterol in people with type 2 diabetes and suggest that the inclusion of cinnamon in the diet of people with type 2 diabetes will reduce risk factors associated with diabetes and cardiovascular diseases.

The incidence of cardiovascular diseases is increased two- to fourfold in people with type 2 diabetes (1). Although the causes of type 2 diabetes and cardiovascular diseases are multifactorial, diet definitely plays a role in the incidence and severity of these diseases. The dietary components beneficial in the prevention and treatment of these diseases have not been clearly defined, but it is postulated that spices may play a role. Spices such as cinnamon, cloves, bay leaves, and turmeric display insulin-enhancing activity in vitro (23). Botanical products can improve glucose metabolism and the overall condition of individuals with diabetes not only by hypoglycemic effects but also by improving lipid metabolism, antioxidant status, and capillary function (4). A number of medicinal/culinary herbs have been reported to yield hypoglycemic effects in patients with diabetes. Examples of these include bitter melon, Gymnema, Korean ginseng, onions, garlic, flaxseed meal, and specific nutrients including -lipoic acid, biotin, carnitine, vanadium, chromium, magnesium, zinc, and vitamins B3, E, and K (5).

Rashwan (6) reported that supplementation of the diet of rabbits with fenugreek decreased total serum lipid level. In rats, curry leaf and mustard seeds decreased total serum cholesterol, LDL cholesterol, and VLDL cholesterol and increased HDL cholesterol levels (7) and reduced cholesterol, triglycerides, and phospholipids in aorta, liver, and heart (8). The LDL and VLDL fractions were also decreased and the HDL fraction was increased. Coriander seeds fed to rats consuming a high-fat diet led to decreased LDL, VLDL, and total cholesterol and increased HDL cholesterol (9). Zhang et al. (10) reported that turmeric may also have a role in reducing the risk of atherosclerosis.

Aqueous extracts from cinnamon have been shown to increase in vitro glucose uptake and glycogen synthesis and to increase phosphorylation of the insulin receptor; in addition, these cinnamon extracts are likely to aid in triggering the insulin cascade system (1112). Because insulin also plays a key role in lipid metabolism, we postulated that consumption of cinnamon would lead to improved glucose and blood lipids in vivo. Therefore, this study was designed to determine whether there is a dose response of cinnamon on clinical variables associated with diabetes and cardiovascular diseases in people with type 2 diabetes.

This study was conducted in the Department of Human Nutrition, NWFP Agricultural University, Peshawar, Pakistan and was approved by the Ethics Committee and Human Studies Review Board of the University of Peshawar. Selection criteria for the study included the following for people with type 2 diabetes: age 40 years, not on insulin therapy, not taking medicine for other health conditions, and fasting blood glucose levels between 7.8 and 22.2 mmol/l (140400 mg/dl). A total of 60 individuals with type 2 diabetes, 30 men and 30 women, were selected for the study. The mean age of the subjects was 52.0 6.87 years in the placebo groups and 52.0 5.85 years in the groups consuming cinnamon. The duration of diabetes was also similar: 6.73 2.32 years for the placebo group and 7.10 3.29 years for the cinnamon groups. There was also an equal number of men and women in the placebo and cinnamon groups. All subjects were taking sulfonylurea drugs, i.e., glibenclamide; medications did not change during the study.

Cinnamon (Cinnamomum cassia) certified by the Office of the Director, Research and Development/Non-Timber Forest Products, NWFP Forest Department, Peshawar, Pakistan, was used in this study. Cinnamon and wheat flour were ground finely and put into capsules (Mehran Traders Pharmaceutical Suppliers, Peshawar, Pakistan). Each capsule contained either 500 mg of cinnamon or wheat flour. Both the cinnamon and placebo capsules were packaged in plastic bags containing 40 capsules (1 g or two capsules per day for 20 days), 120 capsules (3 g or six capsules per day for 20 days), or 240 capsules (6 g or 12 capsules per day for 20 days) and prepared for distribution to the subjects. When subjects finished testing after the first 20 days, they were given the second package of capsules. Compliance was monitored by capsule count and contact with the subjects. Compliance was considered excellent and all capsules were consumed.

The study was conducted for 60 days with 60 individuals with type 2 diabetes divided randomly into six equal groups. Group 1 consumed two 500-mg capsules of cinnamon per day, group 2 consumed six capsules of cinnamon per day, and group 3 consumed 12 capsules of cinnamon per day. Groups 4, 5, and 6 were assigned to respective placebo groups, which consumed a corresponding number of capsules containing wheat flour. Subjects consumed their normal diets and continued their medications throughout the study. From days 41 to 60, no cinnamon or placebo was given. The 1-g dose of cinnamon and placebo was spread over the day as 0.5 g (one capsule) after lunch and 0.5 g after dinner. The 3-g and 6-g doses of cinnamon and placebo were spread over the day as 1 g (two capsules) and 2 g (four capsules) after breakfast, lunch, and dinner, respectively. The subjects were instructed to take the capsules immediately after meals.

On days 0, 20, 40, and 60, 5 ml of fasting blood was collected from each subject. Blood samples were transferred to sterilized centrifuge tubes and allowed to clot at room temperature. The blood samples were centrifuged for 10 min in a tabletop clinical centrifuge at 4,000 rpm for serum separation. Serum samples were stored in a freezer at 0C for later analyses.

Glucose level was determined using an autoanalyzer (Express Plus; Ciba Corning Diagnostics, Palo Alto, CA). Triglyceride levels were determined by the enzymatic colorimetric method of Werner et al. (13) using an autoanalyzer (Express Plus; Ciba Corning) and an Elitech kit (Meditek Instrument, Peshawar, Pakistan). Cholesterol levels were determined by enzymatic colorimetric method of Allain et al. (14) using the same autoanalyzer. Chylomicrons, VLDL, and LDL were precipitated by adding phosphotungstic acid and magnesium ions to the sample. Centrifugation left only the HDL in the supernatant (15). LDL cholesterol was calculated by dividing the triglycerides by 5 and subtracting the HDL cholesterol (16).

Two-way ANOVA and randomized complete block design were used for statistical analysis (17). Values are means SD.

The addition of 1, 3, or 6 g of cinnamon to the diet led to significant decreases in serum glucose levels after 40 days. Values after 20 days were significantly lower only in the group receiving 6 g of cinnamon (Table 1). At the levels tested, there was no evidence of a dose response because the response to all three levels of cinnamon was similar. Decreases ranged from 18 to 29%. After the subjects no longer consumed the cinnamon for 20 days, glucose levels were significantly lower only in the group consuming the lowest level of cinnamon. Glucose values in the three placebo groups were not significantly different at any of the time points.

The consumption of cinnamon also led to a time-dependent decrease in serum triglyceride levels at all amounts of cinnamon tested after 40 days (Table 2). Values after 20 days were significantly lower only in the group consuming 6 g of cinnamon per day. Decreases after 40 days of cinnamon consumption ranged from 23 to 30%. These data indicate that consumption of cinnamon for 20 days was more beneficial than shorter use for reduction of triglyceride levels in people with type 2 diabetes. The mean fasting serum triglyceride levels of the subjects who consumed 1 g or 3 g of cinnamon per day for 40 days followed by 20 days of not consuming cinnamon were still significantly lower than the mean fasting serum triglyceride levels of the same groups at the beginning of the study. Decreases in the 6-g group were no longer significant. There were no changes in triglyceride levels in any of the three placebo groups (Table 2).

There were also significant decreases in serum cholesterol levels in all three groups consuming cinnamon, and no changes were noted in the respective placebo groups (Table 3). Decreases were significant after 20 days, and values were similar after 40 days, except in the group consuming 3 g per day, which continued to decrease. These decreases in serum cholesterol level ranging from 13 to 26% were maintained even after not consuming additional cinnamon for 20 days (Table 3, last column).

Decreases in LDL were significant in the 3- and 6-g groups after 40 days with decreases of 10 and 24% (Table 4). Decreases in the 1-g group were not significant after 40 days but continued to decline during the washout period and were significant after 60 days (Table 4, last column).

There were nonsignificant changes in HDL in the subjects consuming 1 or 6 g of cinnamon for 40 days. Decreases in the 3-g group were significant after 20 days. These values remained relatively unchanged after the 20-day washout period.

This study demonstrates effects of low levels (16 g per day) of cinnamon on the reduction of glucose, triglyceride, LDL cholesterol, and total cholesterol levels in subjects with type 2 diabetes. The study design serves to replicate the results because there were similar effects at the three doses tested. It is not clear whether even less than 1 g of cinnamon per day would also be beneficial. The data are also reinforced by the observation that there were no significant changes in any of the placebo groups. There were also no problems with compliance or problems associated with the consumption of 6 g of cinnamon per day.

The mechanism of the effects of cinnamon on glucose and blood lipids must be determined. Symptoms of insulin resistance include decreased stimulation of muscle glycogen synthesis as well as defects in glycogen synthase activity and glucose uptake (18). In addition, altered enzymatic activities, such as an increased phosphatase activity and/or seryl phosphorylation of the insulin receptor substrate by glycogen synthase kinase-3 (GSK-3), have also been shown to be involved in some cases of type 2 diabetes (1920). Dephosphorylation of the receptor -subunit is associated with the deactivation of its kinase activity and, therefore, is associated with insulin signal downregulation (21). Maximal phosphorylation of the insulin receptor is associated with increased insulin sensitivity, which is associated with improved glucose and lipid levels. Extracts of cinnamon activated glycogen synthase, increased glucose uptake, and inhibited glycogen synthase kinase-3(1112). Extracts of cinnamon also activated insulin receptor kinase and inhibited dephosphorylation of the insulin receptor, leading to maximal phosphorylation of the insulin receptor (12). All of these effects would lead to increased insulin sensitivity. We have shown that extracts of cinnamon also function as potent antioxidants, which would lead to additional health benefits of this substance (unpublished data). Dhuley (22) showed that cinnamon displays antioxidant activity in rats fed a high-fat diet.

The maintenance of lower serum glucose and lipid levels, even when the individuals were not consuming cinnamon for 20 days, denotes sustained effects of cinnamon, indicating that cinnamon would not need to be consumed every day. The levels of cinnamon tested in this study, 16 g per day, suggest that there is a wide range of cinnamon intake that may be beneficial and that intake of 1 g daily is likely to be beneficial in controlling blood glucose and lipid levels.

In conclusion, cinnamon reduced serum glucose, triglyceride, total cholesterol, and LDL cholesterol levels in people with type 2 diabetes. Because cinnamon would not contribute to caloric intake, those who have type 2 diabetes or those who have elevated glucose, triglyceride, LDL cholesterol, or total cholesterol levels may benefit from the regular inclusion of cinnamon in their daily diet. In addition, cinnamon may be beneficial for the remainder of the population to prevent and control elevated glucose and blood lipid levels.

Effects of cinnamon on glucose levels in people with type 2 diabetes

Effects of cinnamon on triglyceride levels in people with type 2 diabetes

Effects of cinnamon on cholesterol levels in people with type 2 diabetes

Effects of cinnamon on LDL levels in people with type 2 diabetes

This project was funded, in part, by the University Grants Commission/NWFP Agricultural University, Peshawar, Pakistan.

A table elsewhere in this issue shows conventional and Systme International (SI) units and conversion factors for many substances.

Raza A, Movahed A: Current concepts of cardiovascular diseases in diabetes mellitus.

Khan A, Bryden NA, Polansky MM, Anderson RA: Insulin potentiating factor and chromium content of selected foods and spices.

Broadhurst CL, Polansky MM, Anderson RA: Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro.

Bailey CJ, Day C: Traditional plant medicines as treatments for diabetes.

Shapiro K, Gong WC: Natural products used for diabetes.

Rashwan AA: Effects of dietary additions of anise, fenugreek and caraway on reproductive and productive performance of New Zealand White rabbit does.

Khan BA, Abraham A, Leelamma S: Biochemical response in rats to the addition of curry leaf (

Khan BA, Abraham A, Leelamma S: Influence of spices

Chithra V, Leelamma S: Hypolipidemic effect of coriander seeds (

Zhang WL, Liu DW, Wo XD, Zhang YH, Jin MM, Ding ZS: Effects of

on proliferation of cultured bovine smooth muscle cells and on expression of low-density lipoprotein receptor in cells.

Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebrutsen TS, Anderson RA, Graves DJ: Regulation of phosphorylase phosphatase (PTP-1) and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signaling.

Jarvill-Taylor KJ, Anderson RA, Graves DJ: A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3L1 adipocytes.

Werner M, Gabrielson DG, Eastman G: Ultramicrodeterminations of serum triglycerides by bioluminescent assay.

Allain CC, Poon LS, Chon CSG, Richmond U, Fu PC: Enzymatic determination of total serum cholesterol.

Lopes-Virella MF, Stone P, Ellis S, Coldwell JA: Cholesterol determinations in high density liproproteins separated by three methods.

Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge.

. Version 2.00. East Lansing, MI, Michigan State University,

Cline GW, Oetersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI: Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes.

Begum N, Sussman KE, Draznin B: Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities.

Nadiv O, Shinitzke M, Manu H, Hecht D, Roberts CT, LeRoith D, Zick Y: Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats.

Eldar-Finkelman H, Krebs EG: Phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase 3 impairs insulin action.

Dhuley JN: Antioxidant effects of cinnamon (

Sign up to receive current issue alerts

Sign In to Email Alerts with your Email Address

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following

Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes

(Your Name) has forwarded a page to you from Diabetes Care

(Your Name) thought you would like to see this page from the Diabetes Care web site.

Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes

Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes

Increased Second Trimester Maternal Glucose Levels Are Related to Extremely Large-for-Gestational-Age Infants in Women With Type 1 Diabetes

A1C in Gestational Diabetes Mellitus in Asian Indian Women

An Evaluation of Methods of Assessing Impaired Awareness of Hypoglycemia in Type 1 Diabetes

Show more Clinical Care/Education/Nutrition

Copyright Notice/Public Access Policy

BMJ Open – Diabetes Research & Care

Standards of Medical Care in Diabetes

© 2018by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN:1935-5548.

Jurassic World Sequel Falls Short of Previous Installment

Morning Editorial Report Newsletter

U.S. Appeals Ruling Allowing ATT-Time Warner Merger

JJ Hit With $4.7 Billion Jury Verdict in Baby Powder Suit

Fox Gets U.K. Approval to Buy Sky Amid Comcast Bidding War

States Weigh Bets on Mobile Sports Gambling

From Seafood to Mattresses: How the U.S. Tariffs Affect Businesses

Netflix Topples HBO in Emmy Nominations

Walmart in Talks to Move Credit-Card Partnership to Capital One

SEC Probes Why Facebook Didnt Warn Sooner on Privacy Lapse

Broadcom Shares Sink as Latest Deal Puzzles Wall Street

Northrop CEO Wes Bush to Step Down at Years End

South Korea Regulator Says Samsung BioLogics Violated Accounting Rules

Jurassic World Sequel Falls Short of Previous Installment

Movie opens to an estimated $150 million in the U.S. and Canada

Jurassic World: Fallen Kingdom made a healthy debut, but it was 28% below the $208.8 million start for the first Jurassic World.

Universal Pictures/Everett Collection

Another Hollywood franchise has lost a bit of its bite.

Jurassic World: Fallen Kingdom opened to an estimated $150 million in the U.S. and Canada over the weekend. That is a healthy debut by most measures, but 28% below the massive $208.8 million start for the first Jurassic World, which relaunched the 25-year-old dinosaur franchise in 2015.

The new movies, which star Bryce Dallas Howard and Chris Pratt, continue the big screen story started with Steven Spielbergs Jurassic Park in 1993.

Since debuting two weeks ago in some foreign markets, Fallen Kingdom has grossed $561.5 million overseas. Its global total is $711.5 million.

The second Jurassic World could surpass $1 billion world-wide, but is unlikely to come close to the $1.67 billion global total of its predecessor.

A number of big-budget cinematic series have, like Jurassic World, slowed down at the box office in the past year, reflecting the fierce competition for a relatively stable pool of box-office dollars and audiences fickle tastes. Among franchises that have recently seen sequels or spinoffs that grossed significantly less than prior entries are Star Wars, Pitch Perfect, Lego, Pirates of the Caribbean, Cars and Transformers.

In the case of Fallen Kingdom, a sequel to a three-year-old film may have been less special to many moviegoers than the launch of Jurassic World 14 years after the last series entry, the poorly received Jurassic Park III.

We had realistic but aggressive expectations for this movie and it came in at the high end of them, said Universal Pictures president of domestic distribution, Jim Orr.

The big-budget release fromComcastCorp.-owned Universal posted the fourth-highest opening for any film this year.

It comes just a week after Incredibles 2, fromWalt DisneyCo.sPixar Animation Studios, made its debut to $182.7 million. This was the first time ever that movies opened one after another to more than $100 million on nonholiday weekends, according to the National Association of Theatre Owners.

This weekend Incredibles 2 grossed $80.9 million, bringing its domestic total to $350.4 million. That is already higher than the entire run of The Incredibles in 2004.

The other two top openers this year were Avengers: Infinity War, with $257.7 million in April, and Black Panther, with $202 million in February, both fromDisneysMarvel Studios.

Reviews for Fallen Kingdom were mixed, as they were for Jurassic World three years ago. The PG-13 movie drew an array of audiences, including families, despite competition from Incredibles 2, said Mr. Orr.

Overseas, Jurassic World: Fallen Kingdom is doing particularly well in Asian and Latin American countries like China, South Korea and Brazil, where it is roughly matching or exceeding the performance of the original. In Europe, the box office has been behind that of Jurassic World, as in the U.S.

Appeared in the June 25, 2018, print edition as Jurassic World Roars to No. 1.

Three Big Cases Kavanaugh May Help Decide

Gowdy, Strzok Spar Over Controversial Texts

All Hail Saudi Arabias First Female Ride-App Drivers

What Do Trump and Putin Want at the Helsinki Summit?

Michael Cohen Purchases New York Apartment for $6.7 Million

FBIs Strzok Denies Claims of Bias at House Hearing

Columbus Prosecutors Drop Charges Against Stormy Daniels

Chateau Margaux for Seat 2A: Emirates Rewrites Rules for Airlines

Opinion: The Human Cost of Swedens Welfare State

Three Big Cases Kavanaugh May Help Decide

Gowdy, Strzok Spar Over Controversial Texts

All Hail Saudi Arabias First Female Ride-App Drivers

What Do Trump and Putin Want at the Helsinki Summit?

Michael Cohen Purchases New York Apartment for $6.7 Million

FBIs Strzok Denies Claims of Bias at House Hearing

Columbus Prosecutors Drop Charges Against Stormy Daniels

Chateau Margaux for Seat 2A: Emirates Rewrites Rules for Airlines

Opinion: The Human Cost of Swedens Welfare State

Jurassic World sequel falls short of previous installment

Movie opens to an estimated $150 million in the U.S. and Canada

An error has occurred, please try again later.